100 Years of Silence: Suramin's Cancer and Autism Cure Story
In 1916, Bayer developed Suramin calling it Bayer 205 to combat African sleeping sickness. But its formula was a state secret, used by Germany to reclaim lost colonies after World War I. Ernest Fourneau unveiled it in 1924 as Germanin, likely for political and marketing reasons during Germany’s colonial push.
Despite this, Suramin’s potential shone through. It helped patients with ovarian cancer by stopping cell growth and triggering apoptosis, a lifeline for many. For autism, a 2017 study showed children regaining language and social skills, challenging the idea that it’s irreversible. It’s also effective against river blindness and has been tested for prostate cancer, viral infections, and more, offering hope where few treatments exist.
https://patriotnewswire.com/100-years-of-silence-suramins-cancer-and-autism-cure-story/